SUMMARY We retrospectively studied 252 operated and 47 unoperated patients with isolated aortic valve disease. Aortic valve replacement (AVR) was recommended to all patients based on clinical and hemodynamic data. Preoperative hemodynamic and angiographic data were similar in operated and unoperated cohorts. Seventy-one percent of patients received a Bjork-Shiley prosthesis. Operative mortality was 7% for the entire surgical series. For patients with predominant aortic stenosis (AS), survival at 3 years was 87% in operated and 21% in unoperated patients (p < 0.001). For patients with predominant aortic insufficiency (Al), the 5-year survival rate was 86% in operated and 87% in unoperated patients (NS). AVR improved long-term survival in patients with AS who had normal or impaired left ventricular (LV) function. In patients with Al and normal LV function, survival was not improved after AVR, but those with LV dysfunction who were operated on tended to survive longer (NS). Long-term survival of unoperated patients with AI was better than that in unoperated patients with AS.
CORRECT TIMING of valve replacement in patients with chronic left ventricular (LV) overload is a challenging problem, especially in patients with chronic aortic insufficiency (Al). Since prospective studies investigating long-term survival of surgical and'medical patients with severe aortic'valve disease cannot be carried out, retrospective studies are the only approach. To our knowledge, in only one study has longterm survival been compared in surgical and medical cohorts with chronic aortic valve disease.' This study failed to document a significant difference in 5-year survival between operated and unoperated patients. We compared the long-term survival of 252 operated patients with that of 47 unoperated patients who had symptomatic aortic stenosis (AS) or AI.
Methods Patients
Follow-up data of all patients with isolated chronic aortic valve disease to whom operation was recommended between October 1975 and April 1980 were analyzed retrospectively. Aortic valve disease was considered isolated if all of the following were excluded: coronary artery disease (defined as diameter reduction of a major coronary vessel by more than 50%), mitral valve disease except trivial mitral insufficiency, tricuspid valve disease, congenital heart disease, acute AI, and acute endocarditis. Two hundred fifty-two patients were operated (operated cohort), and 47 patients refused the recommended operation (unoperated cohort). The indications for aortic valve replacement (AVR) included at least two of'the following features: severe hemodynamic lesion of aortic valve, symptoms (angina pectoris, syncope, congestive heart failure), the presence or progression of cardiac enlargement on serial chest radiographs, and abnormally low ejection fraction (EF) (54% or less as defined previously2). Categorizing patients according to predominant lesion showed that 144 patients had predominant AS (peak-to-peak transvalvular pressure gradient of 45-150 mm Hg with or without associated aortic regurgitation) and 155 patients had predominant Al (massive regurgitation documented by aortic root angiography,3 with or without peak-to-peak transvalvular pressure gradient of less than 30 mm Hg).
Cardiac Catheterization
All patients underwent right-and left-heart catheterization within 6 months before operation. A #8.5F Brockenbrough catheter was positioned by transseptal puncture into the left ventricle and a pigtail catheter (#7F) was advanced retrogradely into the aortic root. Pressures were recorded on an Oscillomink directwriting system with Statham transducers before injection of contrast material. LV end-diastolic pressure was measured after the "a" wave. The cardiac index was determined by the Fick method. Valve areas were not calculated, because cases with associated angiographically visible mild-to-moderate aortic regurgitation were placed in this AS group. Single-plane 35-mm cineangiograms of the left ventricle were filmed (50 ml Urografin 76) at 50 frames/sec, in the 300 right anterior oblique projection with a Phillips image-intensifier system. Aortic root angiography was performed to estimate the degree of aortic regurgitation. scribed by Cutler and Ederer. 6 The significance of differences in survival curves was determined by the chi-square test described by Mantel,7 and the differences of survival rates at each yearly interval were tested by Z score.8 The statistical significance of differences between two groups was not indicated when the effective number of patients at risk of dying during a yearly interval was less than five. The baseline characteristics were compared by t test or chi-square test.9 Differences were considered significant if p < 0.05. Abbreviations: AS aortic stenosis; aortic insufficiency; 'k = interval (years) after operation (operated cohort) or after cardiac catheterization (unoperated cohort); Nk = alive at beginning of interval; dk died during interval; 1k = lost to follow-up during interval; Wk withdrawn alive during interval; Pk = cumulative proportion surviving; SE = standard error.
Aortic Stenosis
Unoperated patients with severe AS had an overall 2-year survival rate of 21%. Survival of unoperated patients was extremely poor even when preoperative LV function was normal. Rapaport'" analyzed the natural history of AS and reported a 2-year survival rate of 50% in a group of unselected patients who were treated medically. These data demonstrate that operation should be recommended to all patients with AS and a severe hemodynamic lesion, even when LV function is still normal. Operated patients with AS had a rather good prognosis. After AVR, survival of patients with AS and poor LV function was dramatically improved, as was survival of patients with AS and good LV function preoperatively. Improvement of LV function after AVR has been reported. [11] [12] [13] [14] Aortic Insufficiency Chronic Al displays a protracted clinical course. The late appearance of clinical disability after irreversible myocardial damage has occurred imposes a therapeutic dilemma with regard to timing of surgical treatment. ' Rapaport'0 described a 5-year survival rate of 75% in his series of medically treated patients with Al. The unoperated patients in the present series had a 5-year survival rate of 87%. This figure deteriorated with impairment of LV function (table 5). The poorest survival was found when mean left atrial pressure was abnormally elevated (60% at 2 years). However, in the present series it was only possible to show a trend toward better survival among patients with LV dysfunction when operated and unoperated patients were compared. These data support the practice of delaying AVR more in patients with Al than in patients with AS. The data do not allow negative conclusions regarding the effectiveness of AVR in Al, for survival 98 .9% of responders and to patients with known prosthetic heart valves by 81.5%. The majority of dentists prescribe the antibiotics recommended by the AHA, but the dosage, route, frequency and duration of therapy are usually not according to AHA guidelines. AbP completely consistent with these guidelines is prescribed by 15.4% of dentists for patients with heart disease and by only 6.7% of dentists for patients with prosthetic heart valves. The AHA recommends parenteral AbP for most patients with prosthetic heart valves, but approximately 80% of dentists use only oral agents for these patients. We conclude that most dental patients predisposed to SBE receive AbP, but not in accordance with AHA guidelines. The widest deviation occurs among patients with prosthetic heart valves.
SUBACUTE bacterial endocarditis (SBE) is a preventable, potentially devastating complication of heart disease. Often, dental procedures have been implicated causally because they are temporally related to the onset of symptoms and because the alphahemolytic streptococcus, which is indigenous to the oral cavity, is the most common infective organism. The American Heart Association (AHA) has established guidelines for the prophylaxis of SBE among predisposed patients." 2 
